Carotid Artery Disease Clinical Trial
Official title:
CARotid plaqUe StabilizatiOn and Regression With Evolocumab: the CARUSO Study
The CARUSO trial aims at investigating the efficacy of evolocumab in promoting carotid plaque morphological stabilization and regression as compared to traditional lipid lowering therapy (LLT). Primary end-point of the study is the superiority of evolocumab on top of ongoing LLT versus ongoing LLT in carotid plaque morphological stabilization and regression at 6 and 12 months, respectively. Secondary end-points are: LDL-Cholesterol (LDL-C) absolute and percentage changes in the two groups at 12 month follow-up, and adverse cerebrovascular and cardiac events at 12 and 24 months
Optimal lipid-lowering therapy (LLT) is a mainstay for the therapeutic management of atherosclerotic vascular disease. Cardiac and cerebrovascular adverse events and progression of atherosclerosis are, indeed, reduced in proportion to the achieved LDL cholesterol (LDL-C) levels.In addition, regression of atherosclerotic plaques with optimal LLT has been observed. However, optimal LLT with statin and ezetimibe, might be limited by the onset of adverse effects (i.e. disabling myalgias, diarrhea) with are usually dose -dependent, and the maximum tolerated statin dose might be insufficient to reach the recommended LDL-C goals. The advent of proprotein convertase subtilisin kexin type 9 inhibitors (PCSK9i) has allowed the achievement of very low LDL-C levels, and the fulfillment of the recommended LDL-C targets. However, while the experience with PCSK9i in patients with coronary artery disease has been wide, and coronary plaque regression has been documented, little is known regarding carotid plaque regression following therapy with PCSK9i. Only a few case reports have been published, and no observational study has been carried out so far. Furthermore, morphological carotid plaque stabilization has a prognostic role, and the possibility of its early achievement with PCSK9i may be relevant, especially in the context of percutaneous or surgical carotid interventions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02124928 -
Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
|
N/A | |
Active, not recruiting |
NCT01597453 -
NOR-SYS: The Norwegian Stroke in the Young Study
|
N/A | |
Completed |
NCT00744523 -
Proximal Protection With The Mo.Ma Device During Carotid Stenting
|
N/A | |
Completed |
NCT00231231 -
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)
|
Phase 3 | |
Completed |
NCT00597974 -
Neurological Outcome With Carotid Artery Stenting
|
N/A | |
Completed |
NCT00587717 -
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue
|
N/A | |
Completed |
NCT02536378 -
POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE
|
||
Completed |
NCT02126982 -
Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence
|
||
Active, not recruiting |
NCT01445613 -
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
|
N/A | |
Terminated |
NCT01414387 -
Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting
|
N/A | |
Completed |
NCT00403078 -
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
|
||
Completed |
NCT00406055 -
CHOICE: Carotid Stenting For High Surgical-Risk Patients
|
Phase 4 | |
Terminated |
NCT01968226 -
TRACER RGD-K5 Carotid Plaque Imaging Study
|
Phase 2 | |
Completed |
NCT01685567 -
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
|
Phase 3 | |
Completed |
NCT00402740 -
Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)
|
N/A | |
Completed |
NCT00287508 -
Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)
|
Phase 4 | |
Completed |
NCT00178672 -
A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease
|
Phase 4 | |
Recruiting |
NCT02850588 -
SVS VQI TransCarotid Revascularization Surveillance Project
|
||
Completed |
NCT02759653 -
Norwegian Carotid Plaque Study
|
||
Withdrawn |
NCT01042912 -
Frequency Analysis of Carotid Artery Disease
|
N/A |